Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United Kingdom.

ABSTRACT:

Background

A growing body of clinical data highlights the prognostic importance of achieving gross total resection (GTR) in patients with glioblastoma. The aim of this study was to determine nationwide practice and attitudes towards achieving GTR and dealing with residual enhancing disease.

Methods

The study was in 2 parts: an electronic questionnaire sent to United Kingdom neuro-oncology surgeons to assess surgical practice followed by a 3-month prospective, multicenter observational study of current neurosurgical oncology practice.

Results

Twenty-seven surgeons representing 22 neurosurgical units completed the questionnaire. Prospective data were collected for 113 patients from 15 neurosurgical units. GTR was deemed to be achieved at time of surgery in 82% (91/111)

SUBMITTER: Ma R 

PROVIDER: S-EPMC6655490 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature